This modification upregulates IGF2BP2 in glioma, fostering VM (vasculogenic mimicry) formation by stabilizing OIP5‐AS1 and disrupting miR‐495‐3p's inhibition of HIF‐1α and MMP14, critical VM components. Here, IGF2BP2 is linked to central nervous system cancer.